PUBLISHER: Grand View Research | PRODUCT CODE: 1375951
PUBLISHER: Grand View Research | PRODUCT CODE: 1375951
The U.S. ambulatory surgery center market size is expected to reach USD 60.8 billion registering a CAGR of 6.00% during the forecast period, according to a report by Grand View Research, Inc.. The report projects that the U.S. ambulatory surgery center devices market size will reach USD 49.1 billion by 2030, growing at a CAGR of 9.16% during the forecast period. The market is highly fragmented and is expected to witness high competition in the coming years. The centers mainly face competition from HOPDs and new ASCs opening every year. For instance, according to Becker's ASC Review, around 258 new ASCs were opened in the U.S. in 2021.
Ambulatory surgery centers (ASCs) have also undergone significant technological advancements in recent years, with a focus on improving patient outcomes, reducing costs, and enhancing operational efficiency. For instance, the growing use of robotics and 3D printing technology has enabled surgeons to perform more precise and less invasive procedures, resulting in faster recovery times and better patient outcomes. For instance, in July 2020, the Southeastern Spine Institute (SSI) Ambulatory Surgery Center, which is affiliated with United Surgical Partners International (USPI), introduced a new program for robotic-assisted surgery.
The COVID-19 pandemic has significantly impacted the U.S. ASCs market during the initial period, owing to the postponement of nonurgent surgeries and the decline in patient volumes due to stringent guidelines. Post-pandemic patients are shifting from hospital to outpatient settings to treat various disease conditions, contributing to market growth.Moreover, hospitals are shifting toward acquiring ASCs post-pandemic owing to the shift in patient preference for ASCs due to the fear of exposure to COVID-19 in hospitals. For instance, in November 2021, Tenet Healthcare Corporation and United Surgical Partners International (USPI), its subsidiary, entered into a definitive agreement to acquire 92 ASCs owned by SurgCenter Development (SCD).